TABLE 3:
Factor | All responses mean (95% CI) | CA practitioners | FP animal practitioners | E practitioners | Belgium | Czech Republic | France | Germany | Spain | Sweden | UK |
---|---|---|---|---|---|---|---|---|---|---|---|
Training/literature | 2.97 (2.93 to 3.01) | 3.05 | 2.78 | 3.08 | 2.93 | 2.83 | 2.97 | 3.30 | 2.96 | 2.65 | 2.93 |
Experience | 2.75 (2.71 to 2.79) | 2.67 | 2.85 | 3.00 | 2.63 | 2.89 | 2.56 | 3.00 | 2.78 | 2.63 | 2.99 |
Label/leaflet | 2.66 (2.61 to 2.70) | 2.65 | 2.81 | 2.32 | 2.67 | 2.83 | 2.80 | 3.06 | 2.76 | 1.68 | 2.75 |
Antibiogram | 2.60 (2.55 to 2.64) | 2.65 | 2.49 | 2.50 | 2.63 | 2.60 | 2.58 | 3.04 | 2.55 | 2.67 | 2.15 |
University | 2.43 (2.38 to 2.47) | 2.43 | 2.33 | 2.72 | 2.60 | 1.89 | 2.35 | 2.31 | 2.35 | 2.60 | 2.59 |
SPC* | 2.37 (2.32 to 2.41) | 2.42 | 2.45 | 1.81 | 2.35 | 2.74 | 2.44 | 2.37 | 2.44 | 2.18 | 2.10 |
Colleagues | 2.22 (2.17 to 2.25) | 2.10 | 2.28 | 2.76 | 1.96 | 2.37 | 1.82 | 2.48 | 2.31 | 2.58 | 2.63 |
Guidelines | 2.06 (2.01 to 2.10) | 2.07 | 2.08 | 1.94 | 1.63 | 1.77 | 1.83 | 2.03 | 1.76 | 3.24 | 1.91 |
Commercial Info | 1.89 (1.84 to 1.92) | 1.89 | 1.94 | 1.72 | 2.23 | 1.86 | 1.83 | 1.73 | 1.90 | 1.78 | 1.83 |
Official reports | 1.69 (1.64 to 1.73) | 1.72 | 1.65 | 1.65 | 1.93 | 2.20 | 1.42 | 1.58 | 1.63 | 2.31 | 1.33 |
*This is a document which is required within the European Union before any medicinal product is authorised for marketing and is approved by regulators, and which forms the basis of information for health professionals to know how to use the specific product safely and effectively
CA, Companion animal; E, Equine; FP, Food producing; SPC, Summary of product characteristics